ASP7991
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ASP7991, covering 2012-08-30 to 2024-11-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis [Phase 2]